• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者术前肌少症对急性和迟发性术后肺炎的影响。

Effect of Preexisting Sarcopenia on Acute and Late Postoperative Pneumonia Among Patients With Oral Cavity Squamous Cell Carcinoma.

机构信息

1Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan.

2Graduate Institute of Business Administration, College of Management, and.

出版信息

J Natl Compr Canc Netw. 2022 Dec;20(12):1299-1306.e2. doi: 10.6004/jnccn.2022.7063.

DOI:10.6004/jnccn.2022.7063
PMID:36509073
Abstract

BACKGROUND

Whether preexisting sarcopenia is an independent risk factor for postoperative pneumonia (POP) for patients with oral cavity squamous cell carcinoma (OCSCC) remains unclear. Therefore, we conducted a propensity score-matched population-based cohort study to compare the risk of acute and late POP for patients with sarcopenic and nonsarcopenic OCSCC who underwent curative surgery.

PATIENTS AND METHODS

We included patients with OCSCC who underwent curative surgery and categorized them into 2 groups depending on whether they had preexisting sarcopenia. The patients in the sarcopenic and nonsarcopenic groups were matched at a ratio of 2:1.

RESULTS

The matching process yielded 16,257 patients (10,822 without sarcopenia and 5,435 with sarcopenia). In multivariate Cox regression analyses, the adjusted hazard ratio of POP for the group with OCSCC with preexisting sarcopenia was 1.20 (95% CI, 1.14-1.26; P<.0001) compared with the nonsarcopenic group. Among the patients with OCSCC who received curative surgery, those in the sarcopenic group exhibited a higher POP risk than those in the nonsarcopenic group for the following postoperative time periods: 31st to 90th day, 91st day to first year, first to second year, second to third year, third to fourth year, and fourth to fifth year.

CONCLUSIONS

The high incidence of pneumonia persists for a long time in patients with OCSCC who receive curative surgery; this high incidence may even persist for 5 years after surgery, especially in patients with sarcopenia. For susceptible patients who are at risk for OCSCC, sarcopenia prevention measures (eg, exercise and early nutrition intervention) should be implemented.

摘要

背景

口腔鳞状细胞癌(OCSCC)患者术前是否存在肌少症仍是术后肺炎(POP)的独立危险因素尚不明确。因此,我们开展了一项基于倾向评分匹配的人群队列研究,以比较接受根治性手术的肌少症和非肌少症 OCSCC 患者的急性和迟发性 POP 风险。

患者和方法

我们纳入了接受根治性手术的 OCSCC 患者,并根据是否存在术前肌少症将其分为 2 组。肌少症和非肌少症组按 2:1 的比例进行匹配。

结果

匹配过程得到 16257 例患者(非肌少症 10822 例,肌少症 5435 例)。多变量 Cox 回归分析显示,与非肌少症组相比,术前存在肌少症的 OCSCC 患者 POP 的调整后危险比为 1.20(95%CI,1.14-1.26;P<.0001)。在接受根治性手术的 OCSCC 患者中,与非肌少症组相比,肌少症组在以下术后时间点的 POP 风险更高:第 31-90 天、第 91 天至第 1 年、第 1 年至第 2 年、第 2 年至第 3 年、第 3 年至第 4 年和第 4 年至第 5 年。

结论

接受根治性手术的 OCSCC 患者的肺炎发病率高且持续时间长;这种高发病率甚至可能在手术后 5 年内持续存在,尤其是在肌少症患者中。对于存在 OCSCC 风险的易感患者,应采取肌少症预防措施(如运动和早期营养干预)。

相似文献

1
Effect of Preexisting Sarcopenia on Acute and Late Postoperative Pneumonia Among Patients With Oral Cavity Squamous Cell Carcinoma.口腔鳞状细胞癌患者术前肌少症对急性和迟发性术后肺炎的影响。
J Natl Compr Canc Netw. 2022 Dec;20(12):1299-1306.e2. doi: 10.6004/jnccn.2022.7063.
2
Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia.口腔鳞状细胞癌合并肌肉减少症患者根治性手术后手术并发症的比较。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):576-584. doi: 10.1002/jcsm.13162. Epub 2022 Dec 23.
3
Comparison of medical resource consumption between oral cavity squamous cell carcinoma with and without sarcopenia: A nationwide population-based cohort study.口腔鳞状细胞癌伴发和不伴发肌肉减少症患者的医疗资源消耗比较:一项基于全国人群的队列研究。
Head Neck. 2023 Jul;45(7):1717-1727. doi: 10.1002/hed.27383. Epub 2023 May 4.
4
Effect of Pre-Existing Sarcopenia on Oncological Outcomes for Oral Cavity Squamous Cell Carcinoma Undergoing Curative Surgery: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study.术前存在的肌肉减少症对接受根治性手术的口腔鳞状细胞癌肿瘤学结局的影响:一项倾向评分匹配的全国性基于人群的队列研究。
Cancers (Basel). 2022 Jul 1;14(13):3246. doi: 10.3390/cancers14133246.
5
Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.放疗后与散发性口腔鳞状细胞癌的临床结局、病理特征和免疫相关特征比较。
JAMA Netw Open. 2023 Jul 3;6(7):e2323890. doi: 10.1001/jamanetworkopen.2023.23890.
6
Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study.根治性放疗或手术治疗老年和超高龄口腔鳞癌患者:一项基于倾向评分匹配的全国性基于人群的队列研究。
Radiother Oncol. 2020 Oct;151:214-221. doi: 10.1016/j.radonc.2020.08.016. Epub 2020 Aug 29.
7
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.基于台湾注册登记的全国性队列研究的结果:接受手术治疗的 pT4a 和 pT4b 口腔鳞状细胞癌患者的临床结局。
Oral Oncol. 2022 Mar;126:105750. doi: 10.1016/j.oraloncology.2022.105750. Epub 2022 Feb 2.
8
Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.新辅助帕博利珠单抗治疗口腔鳞状细胞癌与初治患者术后不良事件的相关性。
JAMA Otolaryngol Head Neck Surg. 2022 Oct 1;148(10):935-939. doi: 10.1001/jamaoto.2022.2291.
9
Relevance of sarcopenia in elderly patients undergoing surgery for oral squamous cell carcinoma.老年口腔鳞状细胞癌患者行手术治疗时肌少症的相关性。
Br J Oral Maxillofac Surg. 2024 Feb;62(2):184-190. doi: 10.1016/j.bjoms.2023.11.017. Epub 2023 Dec 5.
10
Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.早期复发是口腔鳞状细胞癌患者生存结局的不良预后因素:来自全国登记研究的结果。
BMC Cancer. 2023 Feb 7;23(1):126. doi: 10.1186/s12885-023-10602-1.

引用本文的文献

1
Impact of perioperative dexmedetomidine on recurrence and survival outcomes in oral cavity squamous cell carcinoma.围手术期右美托咪定对口腔鳞状细胞癌复发及生存结局的影响
BMJ Health Care Inform. 2025 Jul 7;32(1):e101344. doi: 10.1136/bmjhci-2024-101344.
2
The impact of smoking on postoperative complications following elective off-pump CABG in an ERAS setting.在加速康复外科(ERAS)背景下,吸烟对择期非体外循环冠状动脉旁路移植术(CABG)术后并发症的影响。
J Anesth. 2025 Apr 9. doi: 10.1007/s00540-025-03488-9.
3
Metformin Against Herpes Zoster in Colon Cancer Patients with Type 2 Diabetes: A PSM Analysis.
二甲双胍对2型糖尿病结肠癌患者带状疱疹的影响:倾向评分匹配分析
J Cancer. 2025 Jan 1;16(4):1054-1065. doi: 10.7150/jca.98852. eCollection 2025.
4
Sarcopenia and risk of postoperative pneumonia: a systematic review and meta-analysis.肌肉减少症与术后肺炎风险:一项系统评价和荟萃分析
J Nutr Health Aging. 2025 Mar;29(3):100457. doi: 10.1016/j.jnha.2024.100457. Epub 2024 Dec 23.
5
Association between sarcopenia and outcomes of surgically treated oral squamous cell carcinoma: a systematic review and meta-analysis.肌肉减少症与手术治疗的口腔鳞状细胞癌预后之间的关联:一项系统评价和荟萃分析。
Front Oncol. 2024 Nov 1;14:1445956. doi: 10.3389/fonc.2024.1445956. eCollection 2024.
6
Statin Therapy Reduces Radiation-Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy.他汀类药物治疗可降低接受辅助放疗的乳腺癌患者的放射性心脏毒性。
J Am Heart Assoc. 2024 Oct 15;13(20):e036411. doi: 10.1161/JAHA.124.036411. Epub 2024 Oct 11.
7
Statin therapy enhances survival in unresectable stage III lung squamous cell carcinoma with concurrent chemoradiotherapy.他汀类药物治疗可提高不可切除的 III 期肺鳞状细胞癌同步放化疗患者的生存率。
Am J Cancer Res. 2024 Jun 15;14(6):2957-2970. doi: 10.62347/NZHY5175. eCollection 2024.
8
Sarcopenia and diabetes-induced dementia risk.肌肉减少症与糖尿病诱发的痴呆风险。
Brain Commun. 2023 Dec 20;6(1):fcad347. doi: 10.1093/braincomms/fcad347. eCollection 2024.